181 related articles for article (PubMed ID: 20559699)
1. Dextran gadolinium complexes as contrast agents for magnetic resonance imaging to sentinel lymph nodes.
Yan GP; Xu W; Yang L; Li L; Liu F; Guo QZ
Pharm Res; 2010 Sep; 27(9):1884-92. PubMed ID: 20559699
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.
Sirlin CB; Vera DR; Corbeil JA; Caballero MB; Buxton RB; Mattrey RF
Acad Radiol; 2004 Dec; 11(12):1361-9. PubMed ID: 15596374
[TBL] [Abstract][Full Text] [Related]
3. Porphyrin-containing Gadolinium Complex as a Tumor-targeting Magnetic Resonance Imaging (MRI) Contrast Agent.
Ouyang YH; Xu W; Zhou CK; Liu F; Li B; Yan GP; Yang L; Chen S; Jiang C
Curr Drug Deliv; 2018; 15(7):972-978. PubMed ID: 29629659
[TBL] [Abstract][Full Text] [Related]
4. Porphyrin-containing polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents.
Yan GP; Li Z; Xu W; Zhou CK; Yang L; Zhang Q; Li L; Liu F; Han L; Ge YX; Guo JF
Int J Pharm; 2011 Apr; 407(1-2):119-25. PubMed ID: 21272626
[TBL] [Abstract][Full Text] [Related]
5. [An experimental study of the cervical lymphatic imaging in interstitial magnetic resonance lymphography of tongue using Dextran-DTPA-Gd].
Wang ZF; Feng YY; Liu SE; Li W; Wan SB; Xu WJ; Jiang T; Shang W
Shanghai Kou Qiang Yi Xue; 2012 Jun; 21(3):283-6. PubMed ID: 22885488
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between Gd-DTPA-enhanced MRI and USPIO-enhanced MRI in diagnosing benign and metastatic cervical lymph nodes in rabbit models].
Feng Y; Zhang GX; Wang H; Hu YS; Wang XF; Zheng LF
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):813-8. PubMed ID: 21223685
[TBL] [Abstract][Full Text] [Related]
7. Interstitial magnetic resonance lymphography using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid in rabbits with lymph node metastasis.
Tsuda N; Tsuji T; Kato N
Invest Radiol; 2005 May; 40(5):306-12. PubMed ID: 15829827
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.
Loubeyre P; Canet E; Zhao S; Benderbous S; Amiel M; Revel D
Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of Gd-DTPA and HSA-Gd-DTPA in magnetic resonance lymphography].
Wu YK; Fang TS; Chen DC; Liu GQ; Xu YK
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1597-600. PubMed ID: 17959548
[TBL] [Abstract][Full Text] [Related]
11. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping.
Melancon MP; Wang Y; Wen X; Bankson JA; Stephens LC; Jasser S; Gelovani JG; Myers JN; Li C
Invest Radiol; 2007 Aug; 42(8):569-78. PubMed ID: 17620940
[TBL] [Abstract][Full Text] [Related]
12. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
13. Enhanced conjugation stability and blood circulation time of macromolecular gadolinium-DTPA contrast agent.
Jenjob R; Kun N; Ghee JY; Shen Z; Wu X; Cho SK; Lee DH; Yang SG
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():659-64. PubMed ID: 26838894
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous Enhancement Pattern in DCE-MRI Reveals the Morphology of Normal Lymph Nodes: An Experimental Study.
Bontempi P; Busato A; Conti G; Della Sala SW; Marzola P; Farace P
Contrast Media Mol Imaging; 2019; 2019():4096706. PubMed ID: 31089325
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid.
Fujimoto Y; Okuhata Y; Tyngi S; Namba Y; Oku N
Biol Pharm Bull; 2000 Jan; 23(1):97-100. PubMed ID: 10706419
[TBL] [Abstract][Full Text] [Related]
17. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging.
Kobayashi H; Kawamoto S; Bernardo M; Brechbiel MW; Knopp MV; Choyke PL
J Control Release; 2006 Apr; 111(3):343-51. PubMed ID: 16490277
[TBL] [Abstract][Full Text] [Related]
18. In vivo cleavage rate of a dextran-bound magnetic resonance imaging contrast agent: preparation and intravascular pharmacokinetic characteristics in the rabbit.
Hals PA; Sontum PC; Holtz E; Klaveness J; Rongved P
Curr Drug Deliv; 2013 Feb; 10(1):134-43. PubMed ID: 22452401
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes.
Huang M; Huang ZL; Bilgen M; Berkland C
Nanomedicine; 2008 Mar; 4(1):30-40. PubMed ID: 18201943
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.
Sun J; Zhang S; Jiang S; Bai W; Liu F; Yuan H; Ji J; Luo J; Han G; Chen L; Jin Y; Hu P; Yu L; Yang X
J Biomed Nanotechnol; 2016 Sep; 12(9):1709-23. PubMed ID: 29345451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
